Remove 2006 Remove Clinical Trials Remove Food
article thumbnail

Article: UC Berkeley Center for the Science of Psychedelics – Psychedelics and the Law

Cannabis Law Report

In recent years, as more clinical trial results show that psychedelics can be used in conjunction with therapy to treat illnesses like depression and post-traumatic stress disorder, legislators pushed to make certain substances available in certain settings. Psychedelics and the United States Food and Drug Administration.

Law 74
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

The Cannabis sativa plant has an incredibly multi-layered, rich, and versatile history of human uses for food and fibre, as well as recreational, and religious and spiritual purposes throughout the world (McPartland and Hegman 2018 ; Aldrich 1997 ; Touw 1981 ; Li 1974 ; Bonini et al. Straus and Giroux, New York: Farrar; 2006.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45
article thumbnail

Why Does Marijuana Make You Lose Weight?

CannaMD

The impact of diet on the endocannabinoid system is predicted to vary as different populations consume different proportions of green vegetables, industrially produced animals, oceanic fishes, and processed foods. As counterintuitive as it might sound, this conclusion is actually in line with a growing number of studies.

Marijuana 107
article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. Cell Calcium 39 (2006) 155–162.